|
Real-time Estimate
Cboe BZX
17:04:35 03/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 16.96 USD | -0.79% |
|
-0.44% | +35.06% |
| 08-28 | Shield Therapeutics to Take Over US Commercialization of ACCRUFeR | MT |
| 08-27 | Shield Therapeutics takes full control of ferric maltol product in US | AN |
| Market Cap | 19.63B 16.93B 15.95B 14.53B 27.17B 1,854B 27.37B 189B 73.3B 948B 73.71B 72.1B 3,114B | P/E 2026 * |
81.1x | P/E 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise Value | 31.69B 27.34B 25.76B 23.47B 43.87B 2,994B 44.19B 305B 118B 1,531B 119B 116B 5,028B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 2.04x |
| Free-Float |
91.44% | Yield 2026 * |
2.98% | Yield 2027 * | 3.05% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTRS | Delayed | |
Tradegate
| VIA | Real-time | |
|
CBOE
| VTRS | Real-time | |
|
Xetra
| VIA | Delayed | |
|
Boerse Muenchen
| VIA | Real-time | |
|
Mexican S.E.
| VTRS * | End-of-day quote | |
|
Deutsche Boerse AG
| VIA | Delayed | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| VTRS | End-of-day quote | |
|
Börse Stuttgart
| VIA | Delayed | |
|
Borsa Italiana
| 1VTRS | End-of-day quote | |
|
London S.E.
| 0A5V | Delayed | |
|
Swiss Exchange
| VTRS | Delayed | |
|
Swiss Exchange
| VTRS | Delayed | |
|
CBOE
| 0A5V | Real-time |
Last Transcript : Viatris Inc.
| 1 day | -0.97% | ||
| 1 week | -0.44% | ||
| Current month | +1.85% | ||
| 1 month | -4.62% | ||
| 3 months | +8.07% | ||
| 6 months | +12.93% | ||
| Current year | +35.06% |
| 1 week | 16.12 |  | 17.28 |
| 1 month | 15.88 | | 18.39 |
| Current year | 12.19 | | 18.39 |
| 1 year | 9.42 | | 18.39 |
| 3 years | 6.85 | | 18.39 |
| 5 years | 6.85 | | 18.39 |
| 10 years | 6.85 | | 47.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 01/04/2023 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 08/05/2026 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 16/11/2020 |
James Kilts
BRD | Director/Board Member | 78 | 16/11/2020 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 16/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/15/26 A | Exercice | Chief Administrative Officer | 63,631 | 0.0054% | ||
| 6/30/26 A | Free | Director | 2,756 | 0.0002% | ||
| 6/30/26 A | Free | Director | 2,362 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -0.44% | +59.38% | +58.33% | 19.63B | |
| -0.63% | -3.16% | +54.36% | +104.03% | 1,034B | |
| -0.03% | +2.98% | +53.76% | +70.33% | 663B | |
| -0.84% | -0.31% | +21.47% | +76.14% | 462B | |
| +2.18% | -2.61% | +31.54% | +37.59% | 344B | |
| +0.26% | +4.73% | +26.64% | +46.62% | 307B | |
| +1.65% | -0.66% | -1.44% | +12.57% | 251B | |
| -0.43% | +0.42% | +54.60% | +72.76% | 239B | |
| +0.99% | +2.30% | -17.17% | -53.91% | 207B | |
| -0.50% | -0.11% | +31.60% | +97.84% | 186B | |
| Average | +0.11% | -0.49% | +31.47% | +52.23% | 371.3B | |
| Weighted average by Cap. | -0.04% | -0.83% | +36.90% | +66.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.78B 12.75B 12.01B 10.95B 20.46B 1,396B 20.61B 142B 55.2B 714B 55.51B 54.29B 2,345B | 15.03B 12.97B 12.21B 11.13B 20.8B 1,420B 20.96B 145B 56.12B 726B 56.43B 55.2B 2,384B |
| Net income | -27.26M -23.52M -22.15M -20.18M -37.72M -2.57B -38.01M -262M -102M -1.32B -102M -100M -4.32B | 340M 293M 276M 252M 470M 32.11B 474M 3.27B 1.27B 16.41B 1.28B 1.25B 53.92B |
| Net Debt | 12.07B 10.41B 9.81B 8.93B 16.7B 1,140B 16.82B 116B 45.05B 583B 45.31B 44.32B 1,914B | 11.08B 9.56B 9B 8.2B 15.33B 1,047B 15.45B 107B 41.37B 535B 41.6B 40.69B 1,758B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | $16.85 | -1.43% | 189,198 |
| 02/09/26 | $17.09 | +2.77% | 7,834,481 |
| 01/09/26 | $16.63 | +0.73% | 6,527,492 |
| 31/08/26 | $16.51 | +1.04% | 12,669,710 |
| 28/08/26 | $16.34 | -3.26% | 6,218,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
